ebomi
Colour theme
Sign in
Insider · CIK 0001352546

Flynn James E

CIK 0001352546 Name as filed on the most recent filing

Filed as Flynn James E (269)

1,449 transaction lines · from 269 filings · filed 2006-02-08 to 2026-03-02 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised. The 40 most recent are shown; the catalog may hold more for this insider.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

10 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-27 05:24 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2022-12-20 S, Open-market sale Oncorus, Inc.ONCR 2,034, disposed Open Form 4 filing 0001193805-22-001764
2022-12-20 S, Open-market sale Oncorus, Inc.ONCR 501, disposed Open Form 4 filing 0001193805-22-001764
2022-12-19 S, Open-market sale Oncorus, Inc.ONCR 3 lines 28,918, disposed Open Form 4 filing 0001193805-22-001764
2022-12-15 S, Open-market sale Oncorus, Inc.ONCR 3 lines 1,205, disposed Open Form 4 filing 0001193805-22-001734
2022-12-14 S, Open-market sale Oncorus, Inc.ONCR 3 lines 3,268, disposed Open Form 4 filing 0001193805-22-001734
2022-12-13 S, Open-market sale Oncorus, Inc.ONCR 3 lines 860, disposed Open Form 4 filing 0001193805-22-001734
2022-11-03 P, Open-market purchase Nuvalent, Inc.NUVL 21,775,000, acquired Open Form 4 filing 0001193805-22-001493
2022-09-16 P, Open-market purchase Larimar Therapeutics, Inc.LRMR 4 lines 34,999,990, acquired Open Form 4 filing 0001193805-22-001296
2022-06-06 S, Open-market sale Mirum Pharmaceuticals, Inc.MIRM 6 lines 962,256, disposed Open Form 4 filing 0001193805-22-000932
2022-05-10 P, Open-market purchase PepGen Inc.PEPG 2 lines 4,999,992, acquired Open Form 4 filing 0001193805-22-000766
2021-10-26 P, Open-market purchase Xilio Therapeutics, Inc.XLO 2 lines 12,400,000, acquired Open Form 4 filing 0001193805-21-001508
2021-07-30 P, Open-market purchase Da32 Life Science Tech Acquisition Corp.DALS 16,000,000, acquired Open Form 4 filing 0000899243-21-031411
2021-07-19 P, Open-market purchase Acutus Medical, Inc.AFIB 2 lines 14,999,992, acquired Open Form 4 filing 0001193805-21-001059
2021-07-09 S, Open-market sale Mirum Pharmaceuticals, Inc.MIRM 1,570,328, disposed Open Form 4 filing 0001193805-21-001014
2021-07-07 S, Open-market sale Mirum Pharmaceuticals, Inc.MIRM 108,496, disposed Open Form 4 filing 0001193805-21-000999
2021-07-06 S, Open-market sale Mirum Pharmaceuticals, Inc.MIRM 797,426, disposed Open Form 4 filing 0001193805-21-000999
2021-07-02 S, Open-market sale Mirum Pharmaceuticals, Inc.MIRM 180,300, disposed Open Form 4 filing 0001193805-21-000999
2021-06-30 P, Open-market purchase Larimar Therapeutics, Inc.LRMR 3 lines 5,999,963, acquired Open Form 4 filing 0001193805-21-000974
2021-06-01 P, Open-market purchase Singular Genomics Systems, Inc.OMIC 2 lines 33,000,000, acquired Open Form 4 filing 0001193805-21-000800
2021-05-04 P, Open-market purchase Werewolf Therapeutics, Inc.HOWL 12,800,000, acquired Open Form 4 filing 0001193805-21-000599
2021-03-30 P, Open-market purchase Edgewise Therapeutics, Inc.EWTX 10,000,000, acquired Open Form 4 filing 0001193805-21-000435
2021-02-17 P, Open-market purchase Oncorus, Inc.ONCR 3 lines 5,700,000, acquired Open Form 4 filing 0001193805-21-000245
2021-02-09 P, Open-market purchase Terns Pharmaceuticals, Inc.TERN 11,305,000, acquired Open Form 4 filing 0001193805-21-000151
2021-01-08 S, Open-market sale Lumos Pharma, Inc.LUMO 3 lines 2,376,099, disposed Open Form 4 filing 0001193805-21-000029

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 10
  • Open-market sale 0
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Flynn James E, insider transactions. Retrieved 2026-08-27 from https://ebomi.com/insider/0001352546

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.